# EDGAR Filing Document

**Accession Number:** 0001343882
**File Stem:** 0000950170-25-108969
**Filing Date:** 2025-8
**Character Count:** 12686
**Document Hash:** 8de4482692b0f7533fc239fc2d5d8334
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000950170-25-108969.hdr.sgml**: 20250814

**ACCESSION NUMBER**: 0000950170-25-108969

**CONFORMED SUBMISSION TYPE**: 4

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20250812

**FILED AS OF DATE**: 20250814

**DATE AS OF CHANGE**: 20250814

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Sprecher Jeffrey C
- **CENTRAL INDEX KEY:** 0001343882

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-36198
- **FILM NUMBER:** 251219899

**MAIL ADDRESS:**
- **STREET 1:** 5660 NEW NORTHSIDE DRIVE
- **STREET 2:** 3RD FLOOR
- **CITY:** ATLANTA
- **STATE:** GA
- **ZIP:** 30328
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Intercontinental Exchange, Inc.
- **CENTRAL INDEX KEY:** 0001571949
- **STANDARD INDUSTRIAL CLASSIFICATION:** SECURITY & COMMODITY BROKERS, DEALERS, EXCHANGES & SERVICES [6200]
- **ORGANIZATION NAME:** 09 Crypto Assets
- **EIN:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 5660 NEW NORTHSIDE DRIVE,
- **STREET 2:** THIRD FLOOR
- **CITY:** ATLANTA
- **STATE:** GA
- **ZIP:** 30328
- **BUSINESS PHONE:** 770-857-4700

**MAIL ADDRESS:**
- **STREET 1:** 5660 NEW NORTHSIDE DRIVE,
- **STREET 2:** THIRD FLOOR
- **CITY:** ATLANTA
- **STATE:** GA
- **ZIP:** 30328

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** IntercontinentalExchange Group, Inc.
- **DATE OF NAME CHANGE:** 20130313

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Intercontinental Exchange Group, Inc.
- **DATE OF NAME CHANGE:** 20130312

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 4

### STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

[x] Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Sprecher Jeffrey C<br><sub>(Last) (First) (Middle)</sub><br>5660 NEW NORTHSIDE DRIVE<br><sub>(Street)</sub><br>ATLANTA, GA 30328<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2025-08-12 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[X] Director [ ] 10% Owner<br>[X] Officer (give title below) [ ] Other (specify below)<br>_Chief Executive Officer_ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>Intercontinental Exchange, Inc. [ ICE ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | 3. Transaction Code (V) | 3. Transaction Code (V) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | Code | V | Amount | (A) or (D) | Price | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| Common Stock | 2025-08-12 |  | M |  | 66575<sup>(1)</sup> | A | $57.31 | 1229566<sup>(2)</sup> | D |  |
| Common Stock | 2025-08-12 |  | S |  | 4123<sup>(1)</sup> | D | 182.0652<sup>(3)</sup> | 1225443 | D |  |
| Common Stock | 2025-08-12 |  | S |  | 55252<sup>(1)</sup> | D | 182.9487<sup>(4)</sup> | 1170191 | D |  |
| Common Stock | 2025-08-12 |  | S |  | 2800<sup>(1)</sup> | D | 183.9097<sup>(5)</sup> | 1167391 | D |  |
| Common Stock | 2025-08-12 |  | S |  | 2400<sup>(1)</sup> | D | 185.0309<sup>(6)</sup> | 1164991 | D |  |
| Common Stock | 2025-08-12 |  | S |  | 2000<sup>(1)</sup> | D | 185.676<sup>(7)</sup> | 1162991<sup>(8)(9)(10)</sup> | D |  |
| Common Stock | 2025-08-12 |  | S |  | 7900<sup>(1)</sup> | D | 181.9877<sup>(11)</sup> | 2093805 | I | CPEX |
| Common Stock | 2025-08-12 |  | S |  | 124690<sup>(1)</sup> | D | 182.9405<sup>(12)</sup> | 1969115 | I | CPEX |
| Common Stock | 2025-08-12 |  | S |  | 7046<sup>(1)</sup> | D | 183.7892<sup>(13)</sup> | 1962069 | I | CPEX |
| Common Stock | 2025-08-12 |  | S |  | 5443<sup>(1)</sup> | D | 185.0006<sup>(14)</sup> | 1956626 | I | CPEX |
| Common Stock | 2025-08-12 |  | S |  | 4921<sup>(1)</sup> | D | 185.6123<sup>(15)</sup> | 1951705<sup>(16)</sup> | I | CPEX |
| Common Stock |  |  |  |  |  |  |  | 81570<sup>(17)</sup> | I | By spouse |

---

## Table II - Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | 4. Transaction Code (V) | 4. Transaction Code (V) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Expiration Date | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Underlying Securities | 7. Title and Amount of Underlying Securities | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| Employee Stock Option (right to buy) Holding | $57.31 | 2025-08-12 |  | M |  |  | 66575 | <sup>(18)</sup> | 2027-01-18 | Common Stock | 66575 | $0 | 0 | D |  |

---

### Footnotes:

(1) This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of June 7, 2024.

(2) Amount of securities beneficially owned includes 83 shares acquired under the Intercontinental Exchange, Inc. Employee Stock Purchase Plan on June 30, 2025.

(3) The price range for the aggregate amount sold by the direct holder is $181.54 - $182.53. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.

(4) The price range for the aggregate amount sold by the direct holder is $182.54 - $183.53. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.

(5) The price range for the aggregate amount sold by the direct holder is $183.55 - $184.54. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.

(6) The price range for the aggregate amount sold by the direct holder is $184.55 - $185.54. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.

(7) The price range for the aggregate amount sold by the direct holder is $185.59 - $185.85. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.

(8) The common stock number referred in Table I is an aggregate number and represents 1,079,262 shares of common stock, 26,702 unvested restricted stock units ("RSUs"), and 57,027 unvested performance based restricted stock units ("PSUs"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three-year period, in which 33.33% of the units vest each year.

(9) The satisfaction of the 2023, 2024 and 2025 three-year total shareholder return (TSR) PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2026, February 2027 and February 2028, respectively, and will be reported at the time of vesting. The satisfaction of the 2024 and 2025 three-year earnings before interest, taxes, depreciation, and amortization (EBITDA) PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027 and February 2028, respectively, and will be reported at the time of vesting.

(10) The satisfaction of the performance based restricted stock units granted as Deal Incentive Awards and the corresponding number of shares to be issued pursuant to these awards, will not be determined until December 2026, December 2027 and December 2028 and will be subject to additional time-based vesting conditions and, if applicable, a subsequent one-year holding period.

(11) The price range for the aggregate amount sold by the direct holder is $181.47 - $182.46. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.

(12) The price range for the aggregate amount sold by the direct holder is $182.49 - $183.48. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.

(13) The price range for the aggregate amount sold by the direct holder is $183.49 - $184.48. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.

(14) The price range for the aggregate amount sold by the direct holder is $184.49 - $185.48. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.

(15) The price range for the aggregate amount sold by the direct holder is $185.50 - $185.85. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.

(16) As previously reported, the reporting person also indirectly owns 1,951,705 shares that are beneficially owned directly by CPEX. The reporting person beneficially owns 100% of the equity interest in CPEX. Additionally, as previously reported, the reporting person indirectly owns shares that are beneficially owned directly by the reporting person's spouse for which the reporting person disclaims beneficial ownership.

(17) As previously reported, the reporting person also indirectly owns 81,570 shares that are beneficially owned directly by the reporting person's spouse for which the reporting person disclaims beneficial ownership.

(18) These options are fully vested.

**Signature:** /s/ Octavia N. Spencer, Attorney-in-fact  
**Date:** 2025-08-14

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**